Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) Retrospective Cohort Study

NCT07784387 is registered in ClinicalTrials.gov with Janssen-Cilag Farmaceutica Ltda. as lead sponsor.

NCT NCT07784387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) Retrospective Cohort Study
Lead sponsor
Janssen-Cilag Farmaceutica Ltda.
Phase
Observational
Overall status
Recruiting
Start date
August 25, 2026
Completion date
February 25, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urinary bladder neoplasms